Ensurge’s core technology is solid-state lithium microbatteries featuring an anode-less 11-layer ultrathin structure on a 10-micron stainless steel substrate. They use LiPON solid electrolytes, LCO cathodes, operate at ~3.9 V, and are produced via roll-to-roll printing for scalable fabrication. Designs offer up to 200 Wh/L (projected 750 Wh/L), fast charging (80% in 8 min, full in 1,000 cycle life, enhanced safety, customizable form factors, and SMT assembly compatibility.
Rechargeable solid-state lithium microbatteries ranging from 1 mAh to 100 mAh capacity, featuring anode-less ultrathin design, high energy density, rapid charging, long cycle life, customizable sizes/shapes, and automated SMT assembly compatibility.
In 2025, Ensurge initiated commercial shipments for customer evaluations, delivering its first batch to a Fortune 500 medical device manufacturer and building a pipeline of over 120 prospective customers.
Ensurge is publicly traded on the Oslo Stock Exchange (ENSU) and OTCQB (ENMPY). It has around 14,000 shareholders, with the top 30 holding 55%. Shareholders are 70% Norwegian and 42.8% foreign as of 2025. In 2025, a private placement managed by Arctic Securities and SEB raised NOK50M at NOK1.25 per share; earlier that year, placements raised NOK40M and NOK35–50M. Major investors include Svelland Global Trading Master Fund and DNB Asset Management.
